CLEMASTINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Clemastine, and when can generic versions of Clemastine launch?
Clemastine is a drug marketed by Actavis Mid Atlantic, Apotex Inc, Genus, New Heightsrx, Teva Pharms, Wockhardt Bio Ag, Ani Pharms, L Perrigo Co, Omnivium Pharms, and Pld Acquisitions Llc. and is included in eleven NDAs.
The generic ingredient in CLEMASTINE is clemastine fumarate. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the clemastine fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clemastine
A generic version of CLEMASTINE was approved as clemastine fumarate by GENUS on January 31st, 1992.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CLEMASTINE?
- What are the global sales for CLEMASTINE?
- What is Average Wholesale Price for CLEMASTINE?
Summary for CLEMASTINE
| US Patents: | 0 |
| Applicants: | 10 |
| NDAs: | 11 |
| Drug Prices: | Drug price information for CLEMASTINE |
| DailyMed Link: | CLEMASTINE at DailyMed |
US Patents and Regulatory Information for CLEMASTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Mid Atlantic | CLEMASTINE FUMARATE | clemastine fumarate | SYRUP;ORAL | 074075-001 | Oct 31, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ani Pharms | CLEMASTINE FUMARATE | clemastine fumarate | TABLET;ORAL | 073282-001 | Jan 31, 1992 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| New Heightsrx | CLEMASTINE FUMARATE | clemastine fumarate | SYRUP;ORAL | 074884-001 | Dec 17, 1997 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pld Acquisitions Llc | CLEMASTINE FUMARATE | clemastine fumarate | TABLET;ORAL | 073458-001 | Oct 31, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
